KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Land & Improvements (2016 - 2025)

Historic Land & Improvements for Teva Pharmaceutical Industries (TEVA) over the last 14 years, with Q4 2025 value amounting to $258.0 million.

  • Teva Pharmaceutical Industries' Land & Improvements rose 2112.68% to $258.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $258.0 million, marking a year-over-year increase of 2112.68%. This contributed to the annual value of $258.0 million for FY2025, which is 2112.68% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Land & Improvements stood at $258.0 million for Q4 2025, which was up 2112.68% from $213.0 million recorded in Q4 2024.
  • In the past 5 years, Teva Pharmaceutical Industries' Land & Improvements ranged from a high of $262.0 million in Q4 2021 and a low of $213.0 million during Q4 2024
  • Moreover, its 5-year median value for Land & Improvements was $246.0 million (2022), whereas its average is $245.0 million.
  • Its Land & Improvements has fluctuated over the past 5 years, first plummeted by 1341.46% in 2024, then soared by 2112.68% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Land & Improvements (Quarter) stood at $262.0 million in 2021, then fell by 6.11% to $246.0 million in 2022, then changed by 0.0% to $246.0 million in 2023, then fell by 13.41% to $213.0 million in 2024, then rose by 21.13% to $258.0 million in 2025.
  • Its Land & Improvements was $258.0 million in Q4 2025, compared to $213.0 million in Q4 2024 and $246.0 million in Q4 2023.